Bleeding Pattern Study

• Status: Completed
• Trial end date: 2005-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Contraceptive Agents; Contraceptives, Oral; Dienogest; Nandrolone

Criteria

Inclusion Criteria:

• Healthy female volunteers aged between 18 and 40 years requiring contraception.

Exclusion Criteria:

• Pregnancy or lactation.

• Any conditions that might interfere with the outcome as well as all contraindications for OC use.